Company: ORBS
Filing Date: 2025-04-28
Form Type: 8-K
Source: 0001641172-25-006365
Chunk: 0

Company: Eightco Holdings Inc.
Filing Date: 2025-04-28
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item
5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

On
April 26, 2025, Mary Ann Halford resigned from the Board of Directors (the “ Board”) of Eightco Holdings Inc. (the “ Company”).
Ms. Halford’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s
operations, policies, or practices. On the same date, the Board appointed Nicola Caiano to replace Ms. Halford on the Board. Mr. Caiano
will serve on the Company’s Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee.

Mr.
Caiano has served as Chief Financial Officer of Cytometric Therapeutics, where he leads capital formation strategies to fund clinical
trials for groundbreaking cancer therapies, since December 2024. He has also served as the Founding Partner of Olea Management LLC since
March 2018, where he advises family offices and early-stage companies across diverse industries, including technology, finance, and consumer
goods, on capital raising and mergers and acquisitions. Previously, Mr. Caiano was a Partner and Director of Research at Pinyon Asset
Management, managing a global event-driven equity and credit portfolio, from May 2011 to December 2017. His career also includes senior
roles at Paulson & Co. Inc., J. P. Morgan Chase, and Bear, Stearns & Co. Inc.

Mr.
Caiano holds a Bachelor of Science in Finance and Accounting from New York University’s Stern School of Business, graduating Magna
Cum Laude, and he completed advanced culinary training at The Italian Culinary Academy, where he was Valedictorian.

On
April 28, 2025, the Company issued a press release announcing the foregoing. A copy of the press release is attached to this Current
Report on Form 8-K as Exhibit 99.1.

Item
9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit      Description                                                            
      No.                                                                             
     99.1      Press release dated April 28, 2025                                     
 ──────────────────────────────────────────────────────────────────────────────────────
      104      Cover                                                                  

SIGNATURE

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly